CD40LG and brucellosis: A study investigating the role of Brucella enzyme immunoassay (EIA) and 2-ME tests in brucellosis follow-up revealed that IgM is a safer diagnostic and treatment follow-up option for acute brucellosis, with the potential to prevent approximately half of unnecessary treatments [17].